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he Relation Between Patients’ Outcomes
nd the Volume of Cardioverter-Defibrillator
mplantation Procedures Performed by
hysicians Treating Medicare Beneficiaries
ana M. Al-Khatib, MD, MHS, FACC,* F. Lee Lucas, PHD,‡ James G. Jollis, MD,*
avid J. Malenka, MD,† David E. Wennberg, MD‡
urham, North Carolina; Lebanon, New Hampshire; and Portland, Maine
OBJECTIVES The purpose of this study is to determine if implantable cardioverter-defibrillator (ICD)
implantation should be limited to physicians with high procedural volume.
BACKGROUND Expanding indications for ICDs will result in an increasing number of physicians implanting
these devices.
METHODS Using the 20% Part B Medicare files for 1999 through 2001, we identified new ICD
implantations and the corresponding denominator files. We used Medicare Provider Analysis
and Review hospital records and the appropriate International Classification of Diseases-9
diagnosis and procedure codes to define complications within 90 days. We defined physician
volume categories by assigning one-quarter of the patients to each quartile. A logistic
regression model was used to adjust outcomes for potential confounders.
RESULTS Ninety-day mortality did not differ between patients who had their ICD implanted by
physicians with the highest volume of implants and those who had their ICD implanted by
physicians with the lowest volume of implants (6.2% vs. 5.9%; odds ratio [OR] 0.99; 95%
confidence interval [CI] 0.75 to 1.30). Within 90 days, mechanical complications were
significantly higher in the lowest volume quartile (OR 1.47; 95% CI 1.09 to 1.99) but were
comparable for physicians who implanted at least 11 ICDs per year. The risk of ICD
infection was significantly higher in patients who had their ICD implanted by physicians with
the lowest volume of implants (OR 2.47; 95% CI 1.18 to 5.17).
CONCLUSIONS We observed an association between a higher volume of ICD implants and a lower rate of
mechanical complications and infections. This association suggests that ICD implantation
should not be performed by physicians without regard to their procedural volume. (J Am
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.04.063Coll Cardiol 2005;46:1536–40) © 2005 by the American College of Cardiology Foundation
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Moday, the implantable cardioverter-defibrillator (ICD) is
he most effective therapy at reducing the risk of sudden
ardiac death in various patient populations (1–4). Patients
ith a history of myocardial infarction and left ventricular
jection fraction (LVEF) of 30% or less were shown, in the
ulticenter Automatic Defibrillator Implantation Trial-II
MADIT-II) trial, to have a significantly better survival
See page 1541
ith an ICD (5). A similar improvement in survival was seen
n the Sudden Cardiac Death in Heart Failure Trial (SCD-
eFT) when patients with ischemic or non-ischemic car-
iomyopathy, New York Heart Association functional class
I or III congestive heart failure symptoms, and an LVEF of
5% or less were treated with an ICD (6). Thus, the number
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Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; and ‡Center for
utcomes Research and Evaluation, Maine Medical Center, Portland, Maine. Dr.
l-Khatib receives research funding from Medtronic and Guidant.a
Manuscript received December 28, 2004; revised manuscript received April 11,
005, accepted May 11, 2005.f patients who will require ICD therapy is expected to rise
xponentially. Because the number of invasive electrophysi-
logists may not be enough to meet the rising need for ICD
mplants, it has been suggested that ICD implantation
hould be performed by other cardiologists and surgeons.
For many procedures, there is an association between a
igher procedural volume and improved patient outcomes.
his association has been consistently observed in relation
o several cardiovascular procedures and cancer resections
7–19). Although a few studies have suggested that patients
ndergoing pacemaker implantation have better outcomes if
heir procedures are performed by high-volume physicians,
ittle is known about the relation between patients’ out-
omes and physician and hospital volume of cardioverter-
efibrillator implantations (20–23). The purpose of this
tudy is to determine if ICD implantation should be limited
o physicians with high procedural volume.
ETHODS
ources of data. We obtained the 20% Part B and 100%
edicare Provider Analysis and Review (MEDPAR) filesnd the corresponding denominator files from the Center
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October 18, 2005:1536–40 Volume of Defibrillator Implantations and Outcomesor Medicare and Medicaid Services for the years 1999
hrough 2001. The Part B files contained claims for services
elivered by physicians to a random sample of 20% of
edicare beneficiaries; MEDPAR files contained a record
or each hospitalization for all Medicare beneficiaries, and
he denominator files contained demographic and eligibility
nformation for each Medicare beneficiary and date of
eath.
dentifying ICD placement and the patient cohort. Us-
ng the 20% sample of Part B claims, we identified all
laims with an appropriate current procedural terminology
CPT) code (see Appendix) for placement of a complete
CD for any indication, a valid physician identifier, and a
rocedure date between January 1, 1999 and September 30,
001. These claims were collapsed into a set of unique
atient identifiers that became our study cohort. Using the
enominator file, we excluded patients if they were 65
ears of age at the time of the procedure, not eligible for
oth Part B and Part A programs, or enrolled in a managed
are plan. For patients with data suggestive of more than
ne complete ICD implant, we assessed outcomes for only
he first procedure. Due to lack of data on indication for
CD implantation, we could not determine what percentage
f ICD implantations in this study were for primary versus
econdary prevention of sudden cardiac death.
dentification of covariates and outcomes. Part B claims
or ICD placement were linked to all Part A claims with
he same unique patient identifier. The Part A claims
ith dates of admission and discharge that included the
ate of implantation on the Part B claims were identified
s the index hospitalization. Data from these Part A
laims were used to identify whether the hospitalization
as elective, urgent, or emergent and to assess patient
omorbidities, summarized using a previously validated
harlson comorbidity score (24). This score includes
ancer, liver disease, renal failure, diabetes mellitus,
yocardial infarction, peripheral vascular disease, de-
entia, chronic obstructive pulmonary disease, rheumatic
eart disease, and acquired immunodeficiency syndrome.
ome patients had no evidence of a hospitalization at the
ime of ICD placement. These patients were assumed to
e undergoing elective procedures. They were included in
he multivariate analysis (see the following text) using a
ummy variable for “missing data.”
Outcomes were identified from information on the
ndex Part A and Part B claims and from any claims
vailable within 90 days of the index procedure. We
Abbreviations and Acronyms
CI  confidence interval
ICD  implantable cardioverter-defibrillator
LVEF  left ventricular ejection fraction
MEDPAR  Medicare Provider Analysis and Review
OR  odds ratioooked for the presence of the specific codes for device- felated infections or mechanical complications of the
rocedure during the index hospitalization and during
ubsequent hospitalizations within 90 days from the
rocedure. We assumed that disease codes for infection
nd inflammatory reaction to cardiac device, bacteremia,
nd staphylococcus septicemia represented a procedural
omplication. Mechanical complications refer to those
esulting from a malfunction on the part of the device.
reakdown, displacement, perforation, and protrusion of
he device and/or lead(s) are forms of mechanical com-
lications (25).
hysician ICD volume and other characteristics. Using
he number of Part B claims for ICD placement with a
hysician’s unique identifier, the number of months
etween the first and last ICD claim, and a five-fold
ultiplier given our 20% national sample, we calculated
n average annual volume of ICD placement. Because of
he similarities between ICD and pacemaker implanta-
ion, we used the same method to calculate an annual rate
f pacemaker implantation and controlled for this expo-
ure in our multivariate analysis.
To examine the relationship between physician volume
f ICD implantations and patient outcomes, we exam-
ned a frequency distribution of physician volumes. Using
his information, we created cut points such that roughly
quarter of all patients were associated with physician’s
aving a narrow range of average procedure rates.
tatistical analysis. Categorical variables are summarized
s frequencies. Differences in patient characteristics by
hysician volume category were assessed using the chi-
quare test. Differences in outcomes across physician
olume categories were assessed using the chi-square test
f trend. Multiple logistic regression models were used to
ssess the effect of physician volume category on out-
omes while adjusting for patient characteristics. Patient
haracteristics that we adjusted for included age, gender,
ace, urgency of admission (outpatient procedure, elec-
ive, urgent, emergency), admission for acute myocardial
nfarction, and Charlson comorbidity score. We also
ontrolled for the volume of pacemaker implantations. In
rder to allow a departure from linearity, all variables
ere entered as dummy variables including physician
olume. To account for clustering of patients within
hysician, we used over-dispersed binary logistic models
26). Results were considered significant at p  0.05.
ESULTS
aseline characteristics. Between 1999 to 2001, 1,672
hysicians implanted ICDs in 9,854 patients meeting
tudy criteria. The average annual volume ranged from 1
o 87 with a median of 7 procedures per year. Figure 1
hows the distribution of physicians across strata of
hysician volumes. A total of 62% of physicians per-
ormed 1 to 10 ICD implants per year on 24% of the
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Volume of Defibrillator Implantations and Outcomes October 18, 2005:1536–40atient population while 7% of all physicians performed
29 implants per year on 25% of all patients.
Of 12,830 patients in the 20% Part B sample who
nderwent ICD implantation in the study period, 9,854
et the inclusion criteria. Of these patients, 51.8% were
etween 65 and 75 years of age, 19.3% were 80 years of
ge or older, 21.6% were women, and 92.4% were white.
he Charlson comorbidity score was 0 in 46.1%, 1 in
3.8%, 2 in 14.6%, and 3 or more in 5.5% of the patients.
f all patients, 9.4% had their ICD implanted on
utpatient basis, 29.6% were electively admitted for the
rocedure, and 61% had their ICD implanted during an
rgent or emergency admission. Table 1 shows baseline
haracteristics of patients in the four physician volume
uartiles. As can be seen, there were small differences in
igure 1. Distribution of physicians according to the annual volume of
mplantable cardioverter-defibrillator implantation procedures in Medicare
eneficiaries during each year of the study period.
able 1. Baseline Characteristics of Patients According to Physic
ICD Annualized Volume
1–6
(n  2,487)
7–
(n 
ge (yrs)
65–69 562 (22.6%) 593
70–74 712 (28.6%) 748
75–79 734 (29.5%) 729
80–84 373 (15.0%) 384
85 106 (4.3%) 105
emale 536 (21.6%) 569
ace
White 2,251 (90.5%) 2,386
Black 163 (6.6%) 117
Other 73 (2.9%) 56
harlson comorbidity score
0 1,197 (48.1%) 1,144
1 800 (32.2%) 892
2 350 (14.1%) 388
3 or more 140 (5.6%) 135
rgency of admission
Outpatient 244 (9.8%) 233
Elective 726 (29.2%) 711
Urgent 710 (28.6%) 707
Emergency 807 (32.5%) 908
acemaker annualized volume
1–3 1,309 (52.6%) 586
19 145 (5.8%) 380CD  implantable cardioverter-defibrillator.atient characteristics across quartiles. Patients treated by the
owest volume physicians were slightly more likely to be black
nd slightly less likely to have comorbid conditions.
utcomes. Unadjusted outcomes by physician volume are
hown in Table 2. Mortality rate averaged 2.4% within 30
ays and 5.8% within 90 days. There was no difference in
ortality rates by physician volume. Unadjusted 30-day
echanical complications increased significantly from 3.8%
n patients who underwent ICD implantation by physicians
ith the highest volume of implants to 6.0% in patients who
nderwent ICD implantation by physicians with the lowest
olume of implants (p  0.001). There was a similar
ncrease in mechanical complications within 90 days (p 
.001). The unadjusted 30-day and 90-day ICD infection
ates were significantly higher in patients who had the ICD
mplanted by physicians with the lowest volume of implants
han in patients who had the ICD implanted by physicians
ith the highest volume of implants (p  0.01).
In the adjusted comparison of 90-day outcomes, there
emained no significant difference in mortality across quar-
iles of physician volume (odds ratio [OR] for the lowest vs.
he highest quartile 0.99; 95% confidence interval [CI] 0.75
o 1.30). Mechanical complications were significantly
igher in the lowest volume quartile than the highest (OR
.47; 95% CI 1.09 to 1.99) but were comparable for
hysicians in the second and third volume quartiles. The
isk of ICD infection was significantly higher in patients
ho had their ICD implanted by physicians in all but the
ighest volume quartile (OR for the lowest vs. the highest
uartile 2.47; 95% CI 1.18 to 5.17) (Fig. 2).
olume Quartile
)
12–17
(n  2,336)
18
(n  2,472) p Value
) 507 (21.7%) 564 (22.8%) 0.38
) 690 (29.5%) 727 (29.4%)
) 707 (30.3%) 676 (27.4%)
) 320 (13.7%) 403 (16.3%)
) 112 (4.8%) 102 (4.1%)
) 489 (20.9%) 536 (21.7%) 0.74
) 2,155 (92.3%) 2,313 (93.6%) 0.01
) 137 (5.9%) 121 (4.9%)
) 44 (1.9%) 38 (1.5%)
) 1,104 (47.3%) 1,095 (44.3%) 0.18
) 785 (33.6%) 858 (34.7%)
) 322 (13.8%) 376 (15.2%)
) 125 (5.4%) 143 (5.8%)
) 255 (10.9%) 196 (7.9%) 0.01
) 708 (30.3%) 775 (31.4%)
) 710 (30.4%) 829 (33.5%)
) 663 (28.4%) 672 (27.2%)
0.01
) 349 (14.9%) 182 (7.4%)
) 754 (32.3%) 1,184 (47.9%)ian-V
11
2,559
(23.2%
(29.2%
(28.5%
(15.0%
(4.1%
(22.2%
(93.2%
(4.6%
(2.2%
(44.7%
(34.9%
(15.2%
(5.3%
(9.1%
(27.8%
(27.6%
(35.5%
(22.9%
(14.9%
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October 18, 2005:1536–40 Volume of Defibrillator Implantations and OutcomesISCUSSION
he present study. Our study is the first study to show
n inverse relationship between volume of ICD implan-
ations and patients’ outcomes. Compared with patients
ho had their ICD implanted by physicians with the
ighest volume of ICD implants, patients who had their
CD implanted by physicians with the lowest volume of
CD implants had a 47% higher odds of mechanical
omplications and a 147% higher odds of ICD infection
ithin 90 days after ICD implantation. These findings
re important both to the individual patient who is
onsidering which physician to go to for ICD implanta-
ion and to the general public.
There are at least three possible explanations for the
nverse relationship between volume of ICD implanta-
ions and patients’ outcomes. The first possible explana-
ion is referral bias. Physicians with the lowest volume of
CD implants may have had sicker patients than physi-
ians with the highest ICD implants. Although this is
ot supported by the Charlson comorbidity score data in
ur study, patients who had their ICD implanted by
hysicians with the lowest ICD implants were more
ikely to be admitted to the hospital emergently. Even
fter we adjusted for this factor, however, the volume of
able 2. Unadjusted Mortality and Morbidity Rates According to
Outcome
1–10
(n  2,487)
1
(n 
0-day mortality 63 (2.5%) 59
0-day mortality 147 (5.9%) 145
0-day mechanical complications 149 (6.0%) 103
0-day mechanical complications 174 (7.0%) 126
0-day ICD infection 23 (0.9%) 28
0-day ICD infection 32 (1.3%) 36
CD  implantable cardioverter-defibrillator.
igure 2. Adjusted odds ratios for 90-day complications among Medicare
eneficiaries who underwent implantable cardioverter-defibrillator implan-
ation from 1999 through 2001 by physician quartile. Odds ratios were
djusted for age, gender, race, urgency of admission, Charlson comorbidity
core, acute myocardial infarction, and pacemaker implant volume. Openw
ars  1 to 10; ruled bars  11 to 18; dotted bars  19 to 28; solid bars
29.CD implants was still a significant, independent predic-
or of a better outcome.
The second possible explanation is that high-volume
hysicians are more likely to have better operative skills
hat result from greater experience than low-volume
hysicians and usually practice at high-volume hospitals.
uch hospitals are more likely to have experienced
hysicians and ancillary personnel. The third possible
xplanation is physicians’ training. It is probable that
igh-volume physicians are trained in electrophysiology
nd that low-volume physicians are not.
revious studies. Some investigators have reported on
he relation between volume of procedures and the
utcome of pacemaker implantation (20 –23). Periodic
urveys of cardiac pacing patterns have been conducted
ince 1969 in the U.S. (23). The most recent survey was
one in 1997. It showed that low-volume implanters had a
igher rate of early electrode problems with passive fixation,
nipolar leads, and late electrode problems with atrial leads.
lthough that study targeted information concerning ICD
ractices, it did not report on the relation between volume
f ICD implantation and patients’ outcomes (23). Examin-
ng 632 consecutive pacemaker implantations at a single
nstitution, Parsonnet et al. (21) showed an appreciably
igher incidence of complications for implanters who per-
ormed fewer than 12 pacemaker implantations per year.
imilarly, Tobin et al. (22) found an inverse relationship
etween complication rate and pacemaker implanters’ vol-
me and experience.
raining guidelines. To accommodate the large number
f patients who could benefit from an ICD, the Heart
hythm Society has issued a clinical competency state-
ent on training pathways for ICD implantation by
on-electrophysiologists (27). Training guidelines pro-
osed in this document pertain only to ICD implanta-
ions in patients who have not experienced sustained
entricular tachycardia or fibrillation but who are at high
isk for these life-threatening arrhythmias. Importantly,
hese guidelines only target experienced pacemaker im-
lanters defined as physicians who implant a minimum of
5 pacemakers per year with a minimum of 100 implants
ver the preceding three years. Our results heighten the
eed for strict training guidelines for ICD implanters.
tudy limitations. Our study has some limitations. First,
sician-Volume Quartile
59)
19–28
(n  2,336)
29
(n  2,472)
p Value
(Trend)
%) 49 (2.1%) 66 (2.7%) 0.9
%) 128 (5.5%) 152 (6.1%) 0.8
%) 98 (4.2%) 93 (3.8%) 0.01
%) 114 (4.9%) 109 (4.4%) 0.01
%) 18 (0.8%) 9 (0.4%) 0.01
%) 28 (1.2%) 14 (0.6%) 0.01Phy
1–18
2,5
(2.3
(5.7
(4.0
(4.9
(1.1
(1.4e included only Medicare patients. Because Medicare
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Volume of Defibrillator Implantations and Outcomes October 18, 2005:1536–40atients are older and are more prone to complications,
ur results may not be reproducible in non-Medicare
atients. However, there is little reason to believe that
olume would be less important in younger patients.
econd, because we used administrative data, we may not
ave accounted adequately for differences in severity of
llness of patients among the different quartiles. Third,
he volume of ICD implants for each physician may not
ave been uniform during all three years of the study.
ur analyses did not take this possible variation in
olume of ICD implants into account. Fourth, because
e used administrative data, we could not validate the
oding data with chart review. Although it is possible
hat some outcomes, such as complications, were under-
oded, it is unlikely that undercoding was not random.
onclusions. We conclude that patients who have their
CD implanted by high-volume physicians have lower rates
f mechanical complications and ICD infection than pa-
ients who have their ICD implanted by low-volume phy-
icians. Our findings suggest that ICD implantation should
e directed toward high-volume physicians.
eprint requests and correspondence: Dr. Sana M. Al-Khatib,
uke Clinical Research Institute, P.O. Box 17969, Durham,
orth Carolina 22715. E-mail: alkha001@mc.duke.edu.
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PPENDIX
Event CPT Codes
International
Classification of
Diseases-9 Codes
CD insertion 33249
acemaker insertion 33200, 33201, 33206,
33207, 33208
echanical
complications
Diagnosis codes
996.00, 996.04
nfection Diagnosis code 996.61PT  current procedural terminology; ICD  implantable cardioverter-defibrillator.
